Thèse Amandine Martin - EPHE

111. Herr, H.W. et al. Bacillus Calmette-Guérin therapy alters the progression of superficial
bladder cancer. Journal of clinical oncology : official journal of the American Society
of Clinical Oncology 6, 1450-5(1988).
112. Alexandroff, A.B. et al. BCG immunotherapy of bladder cancer: 20 years on. Lancet
353, 1689-94(1999).
113. Lamm, D.L. et al. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent
TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized
Southwest Oncology Group Study. The Journal of urology 163, 1124-9(2000).
114. Janeway, C.A. How the immune system protects the host from infection. Microbes and
infection / Institut Pasteur 3, 1167-71(2001).
115. Dranoff, G. Cytokines in cancer pathogenesis and cancer therapy. Nature reviews.
Cancer 4, 11-22(2004).
116. Fosså, S.D., Kramar, A. & Droz, J.P. Prognostic factors and survival in patients with
metastatic renal cell carcinoma treated with chemotherapy or interferon-alpha.
European journal of cancer (Oxford, England : 1990) 30A, 1310-4(1994).
117. Kirkwood, J.M., Resnick, G.D. & Cole, B.F. Efficacy, safety, and risk-benefit analysis
of adjuvant interferon alfa-2b in melanoma. Seminars in oncology 24, S16-23(1997).
118. Kirkwood, J. Cancer immunotherapy: the interferon-alpha experience. Seminars in
oncology 29, 18-26(2002).
119. Dutcher, J. Current status of interleukin-2 therapy for metastatic renal cell carcinoma
and metastatic melanoma. Oncology (Williston Park, N.Y.) 16, 4-10(2002).
120. Taneja, S.S. et al. Immunotherapy for renal cell carcinoma: the era of interleukin-2based
treatment. Urology 45, 911-24(1995).
121. Negrier, S. et al. Recombinant human interleukin-2, recombinant human interferon
alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Français dʼImmunothérapie.
The New England journal of medicine 338, 1272-8(1998).
122. Trinchieri, G. & Scott, P. Interleukin-12: basic principles and clinical applications.
Current topics in microbiology and immunology 238, 57-78(1999).
123. Younes, A. et al. Phase II clinical trial of interleukin-12 in patients with relapsed and
refractory non-Hodgkinʼs lymphoma and Hodgkin's disease. Clinical cancer research :
an official journal of the American Association for Cancer Research 10, 5432-8(2004).
124. Erridge, C., Bennett-Guerrero, E. & Poxton, I.R. Structure and function of
lipopolysaccharides. Microbes and infection / Institut Pasteur 4, 837-51(2002).
125. Coley, W.B. The treatment of inoperable sarcoma with the mixed toxins of Erysipelas
and Bacillus prodigious. J. Am. Med. Assoc 31, 389-395(1898).
43